Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KYTHERA Biopharmaceuticals Inc (NASDAQ:KYTH)

74.70
Delayed Data
As of Aug 28
 +0.01 / +0.01%
Today’s Change
29.86
Today|||52-Week Range
76.31
+115.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues13.0M19.7M0.000.00
 
 
 
Cost of Goods Sold1.1M1.3M0.000.00
 
 
 
Depreciation And Amortization54.0K635.0K223.0K303.0K
 
 
 
 
 
 
Operating ExpensesGross Income11.8M17.8M-223.0K-303.0K
 
 
 
 
 
General Expenses22.6M53.7M49.8M78.6M
 
 
 
 
 
Research And Development15.8M43.2M34.0M47.8M
 
 
 
 
 
Total Operating Expenses23.8M55.6M50.1M78.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.8M-35.9M-50.1M-78.9M
 
 
 
 
 
Extraordinary Credit--1.2M0.00--
 
 
Extraordinary Charge--0.000.00-52.8M
 
 
Interest Expense On Debt304.0K0.002.0M4.2M
 
 
 
 
Other Expenses0.00-2.1M0.00-72.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.2M-36.8M-51.9M-135.6M
 
 
 
 
 
Net Income-11.2M-36.8M-51.9M-135.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.4M14.1M19.2M22.5M
 
 
 
 
 
Shares To Calculate EPS Diluted17.4M14.1M19.2M22.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.98-$2.62-$2.71-$6.04
 
 
 
 
 
EPS Diluted-$0.64-$2.62-$2.71-$6.04